Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Cell Press

Tracked across 6 events · 54 articles · First seen Apr 24, 2025 · Last active Aug 25, 2026

Sentiment
14
Attention
4
Events
6
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
1 10
Tech
A study published in Cell Reports on August 19 found that supercentenarians (people aged 110+) have unusually high levels of CD4 cytotoxic T lymphocytes (CD4 CTLs), a rare type of immune cell that can kill…
Impact: Publisher of the journal Cell Reports; disseminated the findings.
Aug 19, 2026 · 6 articles
2 10
Tech
Impact: Publisher of the journal Cell Press Blue; the review's publication enhances its scientific reputation.
Jul 31, 2026 · 20 articles
4 10
Tech
Impact: Cell Press is the publisher of the journal Cell Stem Cell, where the study's findings were published, disseminating this important research.
Jul 02, 2026 · 6 articles
4 50
Tech
Impact: Published the study, lending credibility and visibility to the research.
Jul 31, 2026 · 7 articles
4 0
Tech
Impact: Cell Press is the publisher of the journal Med, where the study was published.
Jun 05, 2026 · 8 articles
2 5
Tech
Impact: Published the study in its journal Device, adding credibility.
Jul 22, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Cell Press live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.